Market Overview

Citigroup Upgrades Acorda Therapeutics, Inc. to Buy, Raises PT to $33.00

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK
RECENT PRO ALERTS

Latest Ratings for ACOR

DateFirmActionFromTo
Dec 2014Goldman SachsInitiates Coverage onNeutral
Oct 2014CitigroupMaintainsNeutral
Oct 2014FBR CapitalMaintainsOutperform

View More Analyst Ratings for ACOR
View the Latest Analyst Ratings

Posted-In: News Upgrades Analyst Ratings

 

Related Articles (ACOR)

Around the Web, We're Loving...

Get Benzinga's Newsletters